DK0796238T3 - Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik - Google Patents
Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetikInfo
- Publication number
- DK0796238T3 DK0796238T3 DK95925889T DK95925889T DK0796238T3 DK 0796238 T3 DK0796238 T3 DK 0796238T3 DK 95925889 T DK95925889 T DK 95925889T DK 95925889 T DK95925889 T DK 95925889T DK 0796238 T3 DK0796238 T3 DK 0796238T3
- Authority
- DK
- Denmark
- Prior art keywords
- fatty acids
- pct
- polyunsaturated fatty
- cosmetics
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
- C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/50—Use of additives, e.g. for stabilisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9408810A FR2722410B1 (fr) | 1994-07-15 | 1994-07-15 | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0796238T3 true DK0796238T3 (da) | 2000-10-02 |
Family
ID=9465440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95925889T DK0796238T3 (da) | 1994-07-15 | 1995-07-17 | Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik |
Country Status (14)
Country | Link |
---|---|
US (1) | US5914347A (de) |
EP (1) | EP0796238B1 (de) |
JP (1) | JPH10508287A (de) |
KR (1) | KR100388818B1 (de) |
AT (1) | ATE193006T1 (de) |
DE (1) | DE69517050T2 (de) |
DK (1) | DK0796238T3 (de) |
ES (1) | ES2150004T3 (de) |
FR (1) | FR2722410B1 (de) |
GR (1) | GR3033990T3 (de) |
MX (1) | MX9701771A (de) |
NZ (1) | NZ289877A (de) |
PT (1) | PT796238E (de) |
WO (1) | WO1996002488A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741533B1 (fr) * | 1995-11-28 | 1998-02-06 | Grinda Jean Robert | Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie |
CA2250581C (en) * | 1996-03-28 | 2008-08-12 | Gist-Brocades B.V. | Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
US7138431B1 (en) | 1998-02-23 | 2006-11-21 | Wake Forest University | Dietary control of arachidonic acid metabolism |
FR2802810A1 (fr) * | 1999-12-23 | 2001-06-29 | Grinda Jean Robert | Nouveaux produits cosmetiques et therapeutiques a base de composes lipidiques et leur procede de preparation |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
DE112004001520B4 (de) * | 2003-08-18 | 2008-04-10 | Btg International Ltd. | Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
WO2011053870A1 (en) * | 2009-10-30 | 2011-05-05 | Retrotope, Inc. | Alleviating oxidative stress disorders with pufa derivatives |
JPWO2012153832A1 (ja) | 2011-05-12 | 2014-07-31 | 日本水産株式会社 | 炎症性疾患用皮膚外用組成物 |
LT3101138T (lt) | 2013-12-04 | 2021-07-26 | Nippon Suisan Kaisha, Ltd. | Mikrobinis aliejus, mikrobinio aliejaus gamybos būdas, koncentruotas mikrobinis aliejus, ir koncentruoto mikrobinio aliejaus gamybos būdas |
JP7048976B2 (ja) | 2015-11-23 | 2022-04-06 | レトロトップ、 インコーポレイテッド | 1,4-ジエン系の部位特異的同位体標識 |
EP4107163A4 (de) | 2020-02-21 | 2024-06-19 | Retrotope, Inc. | Verfahren zur isotopenmodifizierung von mehrfach ungesättigten fettsäuren und deren derivaten |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2827452A (en) * | 1955-05-31 | 1958-03-18 | Univ Minnesota | Stabilization of materials |
US3450821A (en) * | 1967-03-02 | 1969-06-17 | Hoffmann La Roche | Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof |
JPS60258139A (ja) * | 1984-06-05 | 1985-12-20 | Nippon Oil & Fats Co Ltd | 金属石けんの水分散体 |
FR2573653B1 (fr) * | 1984-11-23 | 1988-02-26 | Pf Medicament | Compositions pharmaceutiques antiandrogenes a base d'acides gras |
GB8710780D0 (en) * | 1987-05-07 | 1987-06-10 | Scras | Opthalmological application of eicosapentaenoic acid |
-
1994
- 1994-07-15 FR FR9408810A patent/FR2722410B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-17 AT AT95925889T patent/ATE193006T1/de not_active IP Right Cessation
- 1995-07-17 JP JP8504755A patent/JPH10508287A/ja active Pending
- 1995-07-17 PT PT95925889T patent/PT796238E/pt unknown
- 1995-07-17 ES ES95925889T patent/ES2150004T3/es not_active Expired - Lifetime
- 1995-07-17 WO PCT/FR1995/000949 patent/WO1996002488A1/fr active IP Right Grant
- 1995-07-17 US US08/809,198 patent/US5914347A/en not_active Expired - Fee Related
- 1995-07-17 DK DK95925889T patent/DK0796238T3/da active
- 1995-07-17 NZ NZ289877A patent/NZ289877A/en unknown
- 1995-07-17 DE DE69517050T patent/DE69517050T2/de not_active Expired - Fee Related
- 1995-07-17 EP EP95925889A patent/EP0796238B1/de not_active Expired - Lifetime
- 1995-07-17 KR KR1019970701725A patent/KR100388818B1/ko not_active IP Right Cessation
-
1997
- 1997-03-07 MX MX9701771A patent/MX9701771A/es unknown
-
2000
- 2000-07-21 GR GR20000401676T patent/GR3033990T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE193006T1 (de) | 2000-06-15 |
FR2722410B1 (fr) | 1996-10-04 |
EP0796238A1 (de) | 1997-09-24 |
KR970706230A (ko) | 1997-11-03 |
ES2150004T3 (es) | 2000-11-16 |
WO1996002488A1 (fr) | 1996-02-01 |
DE69517050T2 (de) | 2001-01-18 |
PT796238E (pt) | 2000-09-29 |
EP0796238B1 (de) | 2000-05-17 |
NZ289877A (en) | 1998-05-27 |
MX9701771A (es) | 1997-12-31 |
GR3033990T3 (en) | 2000-11-30 |
US5914347A (en) | 1999-06-22 |
JPH10508287A (ja) | 1998-08-18 |
DE69517050D1 (de) | 2000-06-21 |
KR100388818B1 (ko) | 2003-10-17 |
FR2722410A1 (fr) | 1996-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0796238T3 (da) | Fremgangsmåde til stabilisering af polyumættede fedtsyrer og deres anvendelse i terapi og kosmetik | |
ES2261446T3 (es) | Utilizacion de una composicion que inhibe el crecimiento del pelo. | |
NO20005431D0 (no) | Gelérbare farmasøytiske preparater | |
NO971951D0 (no) | Farmasöytiske preparater | |
LV12766A (lv) | Composition of l-dopa esters | |
JP4755985B2 (ja) | 皮膚を美白にするおよび老人斑を処置するのための、ビオチンまたはビオチン誘導体の使用 | |
MY111841A (en) | Injectable liposomal pharmaceutical preparations | |
DK0789580T3 (da) | Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling | |
KR20060027322A (ko) | 세라미드 유형 화합물의 합성 방법 | |
KR960016908A (ko) | 제약학상 담체 | |
BR0009340B1 (pt) | composiÇço adequada para uso na pele ou no cabelo, produto para aplicaÇço na pele ou no cabelo, mÉtodo para preparar uma composiÇço adequada para aplicaÇço na pele ou no cabelo, e, uso de uma composiÇço. | |
JP2993943B2 (ja) | ホスホン酸誘導体とメタ二亜硫酸塩に基づくアスコルビン酸安定化のための安定剤とそれを含有する組成物 | |
HUP9904360A2 (hu) | Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával | |
PT1392335E (pt) | Composições farmacêuticas e/ou cosméticas para o tratamento de celulite e adiposidades localizadas | |
GB2004741A (en) | Cosmetic and pharmaceutical compositions for the skin | |
HUP0004981A2 (hu) | Aminofenolszármazékot tartalmazó kozmetikai készítmény, ennek alkalmazása és eljárás aminofenol származékok oldására | |
HUP0001137A2 (hu) | Bőrápoló szer | |
ES2103369T3 (es) | Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas. | |
JP2001302525A (ja) | 皮膚外用剤 | |
HUP9700842A1 (hu) | Hatóanyagok szabályozott felszabadulását biztosító, stabilizált lipofil mátrixalapú gyógyászati készítmények | |
ATE127465T1 (de) | Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen. | |
JP2007509994A (ja) | アシルリボヌクレオシドおよびアシルデオキシリボヌクレオシド | |
JPH09157138A (ja) | 養育毛剤 | |
ES2172209T3 (es) | Composiciones cosmeticas que contienen acido azelaico. | |
ES2172172T3 (es) | Composiciones farmaceuticas solidas para la administracion por via oral que permiten la liberacion modulada de nicorandil y su procedimiento de preparacion. |